Li Y, Wang JX, Yibi RH. Prediction of lymph node metastasis in early esophageal cancer. World J Gastrointest Surg 2023; 15(10): 2294-2304 [PMID: 37969711 DOI: 10.4240/wjgs.v15.i10.2294]
Corresponding Author of This Article
Ran-Hen Yibi, MBBS, Doctor, Department of Gastroenterology, Lhasa Peolpe’s Hospital, No. 1 Beijing Zhong Road, Chengguan District, Lhasa 850000, Tibet Autonomous Region, China. 18143216011@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Systematic Reviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Li Y, Wang JX, Yibi RH. Prediction of lymph node metastasis in early esophageal cancer. World J Gastrointest Surg 2023; 15(10): 2294-2304 [PMID: 37969711 DOI: 10.4240/wjgs.v15.i10.2294]
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2294-2304 Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2294
Prediction of lymph node metastasis in early esophageal cancer
Yan Li, Jun-Xiong Wang, Ran-Hen Yibi
Yan Li, Ran-Hen Yibi, Department of Gastroenterology, Lhasa People’s Hospital, Lhasa 850000, Tibet Autonomous Region, China
Jun-Xiong Wang, Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100000, China
Jun-Xiong Wang, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing 100000, China
Author contributions: YiBi RH conceived this study; Li Y drafted the article; Wang JX provided critical revision of this article; All authors approved the final version.
Supported byNatural Science Foundation of Tibetan Autonomous Region, No. XZ202101ZR0015G; Medical Program of Group Aid to Tibet, Natural Science Foundation of Tibetan Autonomous Region, No. XZ2021ZR-ZY27(Z).
Conflict-of-interest statement: All the authors declare that they have no competing interests.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ran-Hen Yibi, MBBS, Doctor, Department of Gastroenterology, Lhasa Peolpe’s Hospital, No. 1 Beijing Zhong Road, Chengguan District, Lhasa 850000, Tibet Autonomous Region, China. 18143216011@163.com
Received: June 12, 2023 Peer-review started: June 12, 2023 First decision: August 10, 2023 Revised: August 17, 2023 Accepted: September 4, 2023 Article in press: September 4, 2023 Published online: October 27, 2023 Processing time: 136 Days and 20.2 Hours
Core Tip
Core Tip: In this study, we reviewed factors predicting lymph node metastasis in early esophageal squamous cell carcinoma (ESCC) and early esophageal adenocarcinoma (EAC). Imaging (size), serum microRNA-218, postoperative pathology and immunohistochemical analysis (depth, size, differentiation grade, lymphovascular invasion, neural invasion, PIM-1) were predictive for both ESCC and EAC. Serum markers (thymidine kinase 1; cytokeratin 19 fragment antigen 21-1; stathmin-1) and overexpression of cortactin, mixed-lineage leukaemia 2, and stanniocalcin-1 were predictive for ESCC. Transcription of CD69, myeloid differentiation protein 88 and toll-like receptor 4 and low expression of olfactomedin 4 were predictive for EAC. Six comprehensive models for ESCC were reviewed, and the areas under the curve reached 0.789-0.938.
